NUZ 0.00% 23.0¢ neurizon therapeutics limited

Ann: Extension Study Begins, Analysis Suggests Survival Benefit, page-135

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 660 Posts.
    lightbulb Created with Sketch. 507
    My pick is J & J, Roche, Merck or Eli Lilly, they are all interested in Neurology and Oncology, and have a lot of cash to spend (no other reason).

    But having said that I don’t have shares in them so I couldn’t care who is the winning bidder in the Auction to come. Pfizer can have it, if they are the highest bidder.

    As long as there is a few interested, and they battle it out.

    @Peeteepoo posted this table:

    https://hotcopper.com.au/posts/71907197/single

    https://hotcopper.com.au/data/attachments/5971/5971639-22580dc8d3328291cc9462f068f48d81.jpg
    Havenots
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.